ARTE
COM:ARTEMISHOSPITALS
Artemis Hospitals
- Stock
Last Close
280.30
01/11 13:30
Market Cap
29.88B
Beta: -
Volume Today
23.55K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 65.47M - | 62.07M 5.19% | 64.22M 3.47% | 66.92M 4.21% | 88.45M 32.17% | 101.89M 15.19% | 110.10M 8.06% | 131.94M 19.83% | ||
average payables | 537.39M - | 583.77M 8.63% | 645.33M 10.54% | 705.77M 9.37% | 741.55M 5.07% | 659.41M 11.08% | 586.20M 11.10% | 740.77M 26.37% | ||
average receivables | 485.73M - | 593.21M 22.13% | 614.99M 3.67% | 719.76M 17.03% | 818.05M 13.66% | 695.95M 14.93% | 691.70M 0.61% | 895.64M 29.48% | ||
book value per share | 7.40 - | 8.74 18.16% | 9.71 11.07% | 10.98 13.12% | 22.17 101.82% | 23.66 6.73% | 24.19 2.23% | 25.87 6.96% | 29.14 12.64% | |
capex per share | -0.77 - | -0.79 2.53% | -3.59 352.34% | -2.92 18.87% | -4.33 48.37% | -1.96 54.60% | -2.61 32.70% | -7.84 200.76% | -10.59 35.07% | |
capex to depreciation | -1.34 - | -1.39 3.27% | -5.12 269.83% | -3.41 33.36% | -2.96 13.21% | -1.20 59.53% | -1.67 38.87% | -5.06 204.01% | -4.99 1.43% | |
capex to operating cash flow | -0.31 - | -0.82 164.12% | -1.30 59.99% | -0.85 34.62% | -1.42 66.00% | -0.46 67.25% | -1.27 172.96% | -1.83 44.53% | -1.15 37.03% | |
capex to revenue | -0.04 - | -0.04 6.24% | -0.16 295.97% | -0.12 25.93% | -0.10 14.10% | -0.05 56.08% | -0.08 83.56% | -0.20 132.35% | -0.20 1.19% | |
cash per share | 1.13 - | 0.28 74.87% | 0.45 59.48% | 0.58 27.64% | 0.94 61.55% | 1.18 26.40% | 2.35 98.84% | 1.99 15.19% | 3.68 84.70% | |
days of inventory on hand | 16.61 - | 11.92 28.23% | 11.27 5.45% | 10.64 5.57% | 10.53 1.02% | 15.27 45.02% | 10.00 34.53% | 9.77 2.26% | 8.52 12.82% | |
days payables outstanding | 122.81 - | 109.22 11.06% | 108.54 0.63% | 111.33 2.57% | 111.90 0.51% | 105.98 5.29% | 59.50 43.85% | 47.28 20.54% | 53.71 13.59% | |
days sales outstanding | 40.87 - | 50.87 24.46% | 49.82 2.07% | 43.81 12.05% | 55.83 27.43% | 51.69 7.42% | 52.89 2.33% | 52.08 1.53% | 49.48 4.99% | |
debt to assets | 0.17 - | 0.14 17.62% | 0.16 8.05% | 0.12 25.68% | 0.10 16.60% | 0.11 15.96% | 0.18 60.55% | 0.23 26.60% | 0.24 3.85% | |
debt to equity | 0.37 - | 0.27 27.43% | 0.32 19.20% | 0.23 29.70% | 0.18 19.44% | 0.21 14.93% | 0.34 60.71% | 0.45 33.37% | 0.53 18.06% | |
dividend yield | ||||||||||
earnings yield | 0.04 - | 0.05 16.53% | 0.06 25.06% | 0.06 1.10% | 0.07 21.64% | 0.11 59.17% | 0.02 79.64% | 0.05 124.53% | 0.04 17.64% | |
enterprise value | 4.51B - | 4.69B 3.93% | 4.68B 0.22% | 4.72B 0.93% | 2.90B 38.66% | 1.70B 41.39% | 2.73B 60.65% | 6.22B 128.06% | 9.16B 47.35% | |
enterprise value over ebitda | 10.31 - | 10.65 3.28% | 8.76 17.70% | 7.78 11.26% | 4.30 44.68% | 2.79 35.11% | 8.28 196.48% | 9.50 14.83% | 10.30 8.42% | |
ev to operating cash flow | 8.55 - | 22.88 167.79% | 8.08 64.71% | 6.57 18.68% | 7.16 9.04% | 3.03 57.73% | 10.00 230.49% | 10.45 4.43% | 7.21 31.01% | |
ev to sales | 1.23 - | 1.17 4.94% | 1.02 12.66% | 0.94 7.86% | 0.53 43.57% | 0.30 43.31% | 0.67 122.25% | 1.12 67.88% | 1.24 10.86% | |
free cash flow per share | 1.73 - | 0.18 89.63% | -0.84 566.55% | 0.50 159.94% | -1.27 352.63% | 2.27 278.83% | -0.55 124.07% | -3.55 549.64% | -1.40 60.72% | |
free cash flow yield | 0.08 - | 0.01 89.63% | -0.04 566.55% | 0.02 159.94% | -0.06 352.63% | 0.17 394.74% | -0.02 114.96% | -0.08 212.08% | -0.02 73.44% | |
graham net net | -5.57 - | -5.22 6.40% | -7.53 44.26% | -7.61 1.15% | -13.78 80.99% | -14.48 5.09% | -14.96 3.32% | -18.36 22.76% | -26.34 43.41% | |
graham number | 12.12 - | 14.23 17.34% | 16.77 17.85% | 17.74 5.77% | 27.79 56.68% | 28.21 1.53% | 16.33 42.12% | 36.51 123.59% | 42.77 17.15% | |
income quality | 2.84 - | 0.95 66.69% | 2.14 126.09% | 2.69 25.48% | 1.97 26.52% | 2.83 43.56% | 4.20 48.34% | 1.87 55.48% | 3.29 76.05% | |
intangibles to total assets | 0.01 - | 0.01 10.99% | 0.00 11.75% | 0.01 30.53% | 0.08 1,171.66% | 0.08 6.74% | 0.07 3.94% | 0.06 12.42% | 0.05 16.08% | |
interest coverage | ||||||||||
interest debt per share | 2.75 - | 2.36 14.24% | 3.12 32.39% | 2.48 20.48% | 4.04 62.58% | 4.95 22.66% | 8.14 64.30% | 11.61 42.65% | 15.44 32.98% | |
inventory turnover | 21.98 - | 30.63 39.34% | 32.39 5.76% | 34.30 5.90% | 34.65 1.03% | 23.90 31.04% | 36.50 52.75% | 37.34 2.31% | 42.83 14.70% | |
invested capital | 0.37 - | 0.27 27.43% | 0.32 19.20% | 0.23 29.70% | 0.18 19.44% | 0.21 14.93% | 0.34 60.71% | 0.45 33.37% | 0.53 18.06% | |
market cap | 4.75B - | 4.75B 0.02% | 4.75B 0.00% | 4.75B 0.00% | 2.99B 37.07% | 1.81B 39.32% | 2.92B 60.93% | 6.38B 118.46% | 9.39B 47.31% | |
net current asset value | -982.67M - | -843.51M 14.16% | -1.30B 53.85% | -1.33B 2.85% | -1.48B 11.19% | -1.55B 4.59% | -1.69B 8.80% | -2.21B 31.08% | -3.27B 47.69% | |
net debt to ebitda | -0.54 - | -0.14 75.03% | -0.13 3.09% | -0.04 66.26% | -0.14 208.85% | -0.19 39.13% | -0.58 204.64% | -0.24 58.75% | -0.26 7.18% | |
net income per share | 0.88 - | 1.03 16.53% | 1.29 25.06% | 1.27 1.10% | 1.55 21.64% | 1.50 3.42% | 0.49 67.23% | 2.29 367.40% | 2.79 21.83% | |
operating cash flow per share | 2.51 - | 0.97 61.18% | 2.75 182.73% | 3.42 24.10% | 3.06 10.62% | 4.24 38.64% | 2.06 51.39% | 4.29 108.09% | 9.19 114.49% | |
payables turnover | 2.97 - | 3.34 12.44% | 3.36 0.63% | 3.28 2.50% | 3.26 0.51% | 3.44 5.58% | 6.13 78.11% | 7.72 25.85% | 6.80 11.96% | |
receivables turnover | 8.93 - | 7.18 19.65% | 7.33 2.11% | 8.33 13.70% | 6.54 21.53% | 7.06 8.02% | 6.90 2.27% | 7.01 1.56% | 7.38 5.25% | |
research and ddevelopement to revenue | 0.01 - | 0.01 18.29% | 0.01 5.56% | 0.01 23.90% | 0.02 70.78% | 0.01 30.09% | 0.01 15.16% | |||
return on tangible assets | 0.06 - | 0.06 11.87% | 0.06 1.99% | 0.06 7.42% | 0.04 32.44% | 0.04 9.25% | 0.01 68.08% | 0.05 310.72% | 0.05 5.91% | |
revenue per share | 17.47 - | 19.10 9.35% | 21.82 14.24% | 23.90 9.54% | 41.28 72.72% | 42.68 3.38% | 30.85 27.71% | 39.93 29.44% | 53.30 33.48% | |
roe | 0.12 - | 0.12 1.38% | 0.13 12.59% | 0.12 12.57% | 0.07 39.73% | 0.06 9.51% | 0.02 67.94% | 0.09 336.98% | 0.10 8.16% | |
roic | 0.13 - | 0.11 17.13% | 0.12 10.61% | 0.11 4.73% | 0.08 32.60% | 0.07 12.41% | 0.03 59.40% | 0.08 176.14% | 0.08 3.19% | |
sales general and administrative to revenue | 0.02 - | 0.02 7.66% | 0.01 32.81% | 0.01 47.07% | 0.00 46.60% | 0.01 80.41% | 0.01 1.49% | 0.00 24.17% | ||
shareholders equity per share | 7.40 - | 8.74 18.16% | 9.71 11.07% | 10.98 13.12% | 22.17 101.82% | 23.66 6.73% | 24.19 2.23% | 25.87 6.96% | 29.14 12.64% | |
stock based compensation to revenue | 0.01 - | 0.01 60.89% | ||||||||
tangible asset value | 1.54B - | 1.82B 18.48% | 2.02B 11.10% | 2.28B 12.84% | 2.48B 8.58% | 2.69B 8.45% | 2.77B 3.27% | 3.15B 13.67% | 3.59B 13.70% | |
tangible book value per share | 7.30 - | 8.65 18.51% | 9.61 11.10% | 10.85 12.84% | 18.71 72.54% | 20.29 8.44% | 20.96 3.29% | 22.70 8.31% | 25.92 14.18% | |
working capital | -353.85M - | -282.28M 20.22% | -454.30M 60.94% | -601.57M 32.42% | -641.57M 6.65% | -402.91M 37.20% | -90.06M 77.65% | -111.09M 23.36% | -354.40M 219.02% |
All numbers in (except ratios and percentages)